- Research article
- Open Access
Expression of miR-195 and its target gene Bcl-2 in human intervertebral disc degeneration and their effects on nucleus pulposus cell apoptosis
Journal of Orthopaedic Surgery and Research volume 16, Article number: 412 (2021)
To investigate the expression of miR-195 and its target gene Bcl-2 in intervertebral disc degeneration (IVDD) and its effect on nucleus pulposus (NP) cell apoptosis.
The expressions of miR-195 and Bcl-2 in NP tissues of IVDD patients were quantified by qRT-PCR and western blotting, respectively. NP cells were divided into blank group, TNF-α group, TNF-α + miR-NC group, TNF-α + siBcl-2 group, and TNF-α + miR-195 inhibitors + siBcl-2 group. Cell proliferation was detected by MTT assay, cell apoptosis evaluated by flow cytometry, and mitochondrial membrane potential (MMP) tested by JC-1 staining. Moreover, the function of miR-195 on IVDD in vivo was investigated using a puncture-induced IVDD rat model.
IVDD patients had significantly increased miR-195 expression and decreased Bcl-2 protein expression in NP tissues. The expression of miR-195 was negatively correlated with the expression of Bcl-2 in IVDD patients. Dual-luciferase reporter gene assay indicated that Bcl-2 was a target gene of miR-195. In comparison with blank group, TNF-α group showed decreased cell proliferation and MMP, increased cell apoptosis, upregulated expression of miR-195, Bax, and cleaved caspase 3, and downregulated Bcl-2 protein, while these changes were attenuated by miR-195 inhibitors. Additionally, siBcl-2 can reverse the protective effect of miR-195 inhibitors on TNF-α-induced NP cells. Besides, inhibition of miR-195 alleviated IVDD degeneration and NP cell apoptosis in the rat model.
MiR-195 was significantly upregulated in NP tissues of IVDD patients, and inhibition of miR-195 could protect human NP cells from TNF-α-induced apoptosis via upregulation of Bcl-2.
Intervertebral disc degeneration (IVDD) is one of the major causes of low back pain, seriously endangering the public health and bringing huge economic burdens to the whole world [1, 2]. However, the molecular mechanism of IVDD has not been clearly elucidated and multiple in vivo and in vitro factors may cause IVDD, such as genetic factors, intervertebral disc dystrophy, immunological factors, matrix metalloproteinases, inflammatory mediators, extracellular matrix (ECM) factors, apoptosis, and mechanical overload [3,4,5]. According to a previous study, the inner layer of intervertebral disc is nucleus pulposus (NP) ECM, which contains NP cells, proteoglycan and type II collagen . IVDD occurrence has been generally considered to be associated with excessive apoptosis of NP cells . Thus, inhibiting NP cell apoptosis may promote the synthesis of NP ECM to slow down the IVDD progression, which is of great significance to improve the quality of life of IVDD patients .
MicroRNAs (miRNA) are a class of small single-strand non-coding RNA molecules about 18–25 nt, and play critical regulatory roles in cell differentiation, proliferation and survival . In recent years, miRNA is shown to involve in the development and progression of IVDD, primarily via affecting cell apoptosis, inflammatory signal response, and ECM components [10, 11]. Of note, miR-195, located at chromosome 17p13.1, belongs to the miR-15/16/195/424/497 family, which has differential roles in different diseases . For example, Xiaoming Cao et al. found the increased miR-195 in osteoarthritis, which could affect the collagen synthesis in osteoarthritis progression via targeting PTHrP . Also, miR-195 can target IKKα to enhance the proliferation and inhibit the apoptosis of human umbilical vein endothelial cells (HUVECs) treated with oxygen-glucose deprivation (OGD), as suggested by Xiao-Li Yang et al. . Nevertheless, relevant studies on the role of miR-195 in IVDD are still unclear. Using the target gene prediction website, Bcl-2 was turned out to be a target gene of miR-195. Indeed, the over-expressed Bcl-2 in NP cells can significantly reduce the apoptosis of serum starvation-induced NP cells in the study of Hideki Sudo et al. . Kangcheng Zhao et al. also found silencing miRNA-143 can specifically upregulate Bcl-2 expression to inhibit NP cell apoptosis . Hence, we hypothesized that miR-195 may play its regulatory role in NP cell apoptosis of IVDD through the regulation of Bcl-2.
To this end, this study attempted to investigate the expression of miR-195 and its target gene Bcl-2 in IVDD, and its possible influence in NP cell apoptosis, aiming to provide some new theoretical basis for the targeted therapy of IVDD.
Materials and methods
The experimental protocol in this study was approved by the Ethics Committee of The Second Hospital of Liaocheng Affiliated to Shandong First Medical University. All participants and their guardians were well-informed and signed the informed consent form prior to the study. All animal studies were approved by the Institutional Animal Research Committee of The Second Hospital of Liaocheng Affiliated to Shandong First Medical University.
From January 2018 to December 2019, 12 IVDD patients undergoing discectomy in our hospital were recruited as study subjects (Pfirrmann grade III–V, mean age 41.6 ± 8.3 years). During the same period, the normal NP tissues were obtained from 10 patients (mean age 23.4 ± 5.3 years) with idiopathic scoliosis classified as Pfirrmann grade I or II according to magnetic resonance imaging (MRI). All patients had no history of tumor, tuberculosis, diabetes, chronic infection, and autoimmune diseases. NP tissues from IVDD patients and control patients were quickly collected and stored in liquid nitrogen for later experiments, and all tissues were preserved in cell center of our hospital. Then, the expressions of miR-195 and TNF-α in NP tissues were quantified by qRT-PCR, and Bcl-2 protein expressions were detected by western blotting. Study design is summarized in Fig. 1.
Isolation and culturing of NP cells
Human NP tissues were carefully isolated, washed three times with PBS, cut into 1 mm3 pieces with ophthalmic scissors, and placed in a 15-mL centrifuge tube. At the temperature of 37 °C, NP tissues were digested for 40 min in PBS solution with 0.25% trypsin (Gibco-BRL, Grand Island, NY). The digestive solution was removed, and the left tissues were washed with PBS again. Next, NP tissues were digested for 4 h in PBS solution with 0.025% type II collagen (Invitrogen, USA), followed by filtering, centrifugation, and discarding the upper supernatant. Then, the NP cells were resuspended in DMEM/F12 supplemented with 15% fetal bovine serum (FBS, Gibco-BRL), 100 μg/mL streptomycin, 100 U/mL penicillin, and 1% l-glutamine, and incubated at 37 °C in an atmosphere containing 5% CO2. At 80–90% confluence, cells were digested by 0.25% trypsin solution and subculture in DMEM/F12 supplemented with 15% FBS, 100 μg/mL streptomycin, 100 U/mL penicillin at 37 °C in a humidified 5% CO2 atmosphere. The culture medium was replaced twice every week. The second passage cells were used for subsequent experiments.
Dual-luciferase reporter gene assay
Bioinformatics software was used to predict the target site of Bcl-2 3′UTR to bind to miR-195. Wild-type Bcl-2-Wt 3′UTR and mutant-type Bcl-2-Mut 3′UTR recombinant plasmids were constructed. One day before transfection, cells were digested by trypsin, counted (2 × 105 cells/mL), and inoculated to 24-well plates. Cells were co-transfected with wild-type or mutant-type luciferase reporter gene plasmid, Renilla (pRL-TK) plasmid, and miR-195 mimic or miR-NC in accordance with the instructions of Lipofectamine 2000 kit (Invitrogen, USA). At 24 h after transaction, cells were collected to detect the luciferase activity using dual-luciferase reports gene assay kit (Promega, USA). The ratio of pGL3 firefly luciferase activity to pRL-TK Renilla luciferase activity was regarded as the relative luciferase activity. The experiment was performed three times independently to obtain the mean value.
Grouping and transfection of NP cells
NP cells were divided into 6 groups: blank group (NP cells without any treatment), TNF-α group (NP cells treated with 20 ng/mL TNF-α for 12 h ), TNF-α + miR-NC group (NP cells transfected with miRNA NC prior to TNF-α treatment), TNF-α + miR-195 inhibitors group (NP cells transfected with miR-195 inhibitors prior to TNF-α treatment), TNF-α + siBcl-2 group (NP cells transfected with Bcl-2 siRNA prior to TNF-α treatment), and TNF-α + miR-195 inhibitors + siBcl-2 group (NP cells co-transfected with miR-195 inhibitors and Bcl-2 siRNA prior to TNF-α treatment). MiRNA negative control (NC), miR-195 inhibitors, and Bcl-2 siRNA were all purchased from Shanghai Genechem Co., Ltd. The miR-195 inhibitors could stably suppress the target miR-195 and are designed and optimized for miR-195 loss of function study. When reached 70–80% confluence, cells were transfected with miR-195 inhibitors/miRNA NC/Bcl-2 siRNA at a final concentration of 40 nM for transfection using LipofectamineTM 2000 (Invitrogen, USA) according to the manufacturer’s instructions.
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
Total RNA in NP tissues or cells were extracted using TRIZOL agent, quantified for RNA concentration using an ultraviolet spectrophotometer, and reversely transcribed into cDNA using PrimeScript RT kit (RR014A, Takara Biomedical Technology (Beijing) Co., Ltd., China). Appropriate amount of cDNA was used as template for PCR. Primers were designed using software Primer 5.0 (Table 1) and synthesized by GenScript (Nanjing) Co., Ltd.). qRT-PCR was performed according to instructions of PCR kit (KR011A1, TIANGEN Biotech (Beijing) Co. Ltd., Beijing, China) and reaction conditions included pre-denaturation at 95 °C for 1 min and 40 cycles of denaturation at 95 °C for 10 s, annealing at 60 °C, extending for 40 s. With U6/β-actin as internal reference, 2−△△Ct method was used to calculate the expression of target genes, with △Ct = Ct target gene-Ct internal reference gene, △△Ct=△Ct experiment group-△Ct control group, and relative expression = 2−△△Ct. The experiment was performed three times independently to obtain the mean value.
Total proteins in NP tissues or cells were extracted and quantified for protein concentration with a BCA kit. The protein samples were adjusted to the same level regarding protein content and loading volume. Polyacrylamide gel electrophoresis was performed to separate proteins, which were transferred to polyvinylidene fluoride (PVDF) membranes using semi-dry transfer system (Bio-Rad, USA). The membrane was blocked in skimmed milk at room temperature and washed with PBST buffer, before the addition of primary antibodies for 1 h reaction at room temperature, including rabbit-anti-human Bax, Bcl-2 and cleaved caspase 3, and GAPDH monoclonal antibody (all purchased from Abcam, UK). Next, the membrane was incubated for 1 h with horseradish peroxidase (HRP)-labeled goat-anti-rabbit IgG (Beijing Zhongshan Gold Bridge Biotechnology Co., Ltd.) and rinsed with PBST for 5 times × 3min. Chemiluminescence (ECL) luminescent reagent was used for the visualization of target proteins. With GAPDH protein as loading control, the software Image-pro Plus 6.0 was used to determine the relative expression of target protein. The relative expression of target protein was set as the gray value ratio of target protein to GAPDH. The experiment was performed three times independently to obtain the mean value.
Cell viability detected by MTT assay
NP cells in each group were inoculated to 96-well plates by density of 1 × 104 cells/well. When cell confluence reached 70%, 5 mg/mL MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) solution (ST316, Beyotime Biotechnology) was added to each well by 10 μL/well and cells were cultured at 37 °C for 4 h. After removing the upper clear supernatant, the plate was washed with PBS, followed by addition of dimethylsulfoxide (DMSO) (D5879, Sigma) by 100 μL/well and 10 min of oscillation. At 48 h after inoculation, the optical density (OD) value was determined at wavelength of 492 nm with a Microplate Reader (MK3, Thermo, Pittsburgh, PA, USA). The experiment was performed three times independently to obtain the mean value.
Cell apoptosis detected by flow cytometry
NP cells were digested by 0.25% trypsin (without EDTA) (PYG0107, Wuhan Boster Biological Technology, Ltd., China) in a 15-mL centrifuge tube, centrifuged for 5 min at the speed of 1000 r/min, and washed three times with cold PBS. The clear supernatant was discarded. Next, 400 μL 1 × binding buffer was added to suspend cells, followed by addition of 5 μL Annexin V-FITC for 15 min staining at 4 °C in an avoidance of light, with the addition of 10 μL propidium iodide (PI) staining for 5 min at 4 °C without light. A flow cytometer was used to detect the cell apoptosis, with the excitation wavelength of 488 nm. Passband filter with the wavelength of 515 nm was used to detect FITC fluorescence, and the filter with wavelength of 560 nm was used to detect PI fluorescence. The experiment was performed three times independently to obtain the mean value.
Detection of mitochondrial membrane potential (MMP)
In accordance with instructions of the JC-1 MMP detection kit (TIANGEN Biotech (Beijing) Co., Ltd., China), JC-1 staining solution was added to cells for 20 min of incubation at 37 °C. Next, JC-1 staining buffer was used to wash cells twice. Three hundred microliters of PBS was used to suspend cells before detection with the flow cytometer. The excitation and emission wavelength was 490 nm and 580 nm for red fluorescence, respectively, and 490 nm and 520 nm for green fluorescence, respectively. The experiment was performed three times independently to obtain the mean value.
Establishment of rat IVDD model
Forty male Sprague-Dawley (SD) rats weighted 200–250 g were used in this study. The animals were kept at a constant room temperature of 23 ± 1 °C on a 12-h light/dark cycle and had free access to food and tap water. Rats (n = 40) were randomly divided into four groups (n = 10 per group): sham group, punctured group, punctured + antagomir-control, and punctured + antagomir-195 group. A rat model of IVDD was established using the annulus fibrosus needle puncture method . In brief, the rats were anesthetized by intraperitoneal injection of 10 mg/kg xylazine and 90 mg/kg ketamine hydrochloride. Subsequently, the syringe needle was inserted into the coccygeal discs C6–C7 in a vertical direction, and then rotated in the axial direction by 180° and held for 10 s. A 31-gauge needle was inserted, parallel to the endplates through the AF into the NP, 1.5 mm into the disc to depressurize the nucleus. For the rats in the sham group, the C6–C7 level discs were exposed without needle puncture. The antagomir-195 and antagomir-control were injected into disc C6–C7 of the rats in the punctured + antagomir-195 and punctured + antagomir-195, respectively . The antagomir-195 and antagomir-control were designed and synthesized by RiboBio (Guangzhou, China). After 4 weeks, all rats were sacrificed by lethal anesthetic overdose and discs were collected and used for further analysis.
All rats underwent radiography immediately before the IVDD puncture and 4 weeks after the second injection. The disc height index (DHI) was measured using the method as previously described . Changes in the DHI of the punctured IVDDs were expressed as %DHI (%DHI = post-punctured DHI/pre-punctured DHI × 100%).
HE and TUNEL staining
The paraffin-embedded tissues were cut into 4-μm sections and mounted on slides. The paraffin sections were deparaffinized with xylol and rehydrated. For clearing endogenous peroxidase, the intervertebral discs were treated with PBS containing 0.3% H2O2 for 15 min, and PBST with 1% BSA was applied to block the sample for 30 min. At last, hematoxylin and eosin (HE) staining was applied onto the samples of intervertebral discs. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was performed using a kit based on the manufacturer’s instruction (Promega, Fitchburg, WI, USA). Histological images were analyzed using the BX53 microscope (Olympus Inc., Tokyo, Japan). The grading score of HE staining was made according to the previous study .
All statistical data were analyzed using SPSS 21.0 (SPSS, Inc., Chicago, IL, USA). Measurement data were presented by mean ± standard deviation. Comparison between two groups was analyzed using Student’s t test, while difference among multiple groups was compared using one-way ANOVA followed by a Turkey post hoc test for multiple group comparison. P < 0.05 was regarded as statistical significance.
Expression of miR-195 and Bcl-2 in NP tissues of IVDD patients
The expressions of miR-195 and TNF-α in NP tissue of IVDD patients and control patients were detected by qRT-PCR (Fig. 2A, B). As a result, the miR-195 and TNF-α expression in NP tissues were significantly higher from IVDD patients than those from the control participants (both P < 0.05). Western blotting was performed to detect Bcl-2 protein expression in NP tissues of IVDD patients (Fig. 2C, D). Obviously, IVDD patients had lower Bcl-2 protein level than control participants (P < 0.05). As shown in Fig. 2E, miR-195 expression was negatively correlated with the Bcl-2 expression in NP tissues from IVDD patients (r = − 0.744, P < 0.05).
Targeting relationship between miR-195 and Bcl-2
Biological prediction website (targetscan.org) showed a targeted binding site between miRNA-195 and Bcl-2 (Fig. 3A). The result of dual-luciferase reporter gene assay was displayed in Fig. 3B. As compared with miR-NC group, co-transfection with miR-195 mimic and Bcl-2-Wt 3′UTR can significantly reduce the luciferase activity (all P < 0.05), while the co-transfection of miR-195 mimic and Bcl-2-Mut 3′UTR showed no significant changes in the luciferase activity (all P > 0.05). These results indicated that Bcl-2 was a target gene of miR-195.
Comparison of proliferation and apoptosis of NP cells in each group
As shown in Fig. 4, NP cells in the TNF-α group and TNF-α + miR-NC group had decreased proliferation activity and increased apoptosis rate compared to the blank group (all P < 0.05). In comparison with TNF-α group, cells in the TNF-α + miR-195 inhibitors group had significantly increased proliferation activity but apparently decreased apoptosis rate, while those in the TNF-α + siBcl-2 group had declined proliferation and elevated apoptosis (all P < 0.05). Besides, compared with TNF-α + miR-195 inhibitors group, TNF-α + miR-195 inhibitors + siBcl-2 group was also strikingly reduced in cell proliferation activity and markedly elevated in cell apoptosis (all P < 0.05).
Comparison of the MMP of NP cells
As seen from Fig. 5, compared with the blank group, TNF-α group and TNF-α + miR-NC group declined dramatically in MMP (both P < 0.05), but TNF-α group and TNF-α + miR-NC group had no obvious difference in MMP (P > 0.05). Compared with TNF-α group, TNF-α + miR-195 inhibitors group was increased appreciably in MMP, while TNF-α + siBcl-2 group was decreased in MMP (all P < 0.05). In addition, in comparison with TNF-α + miR-195 inhibitors group, TNF-α + miR-195 inhibitors + siBcl-2 group also declined substantially in MMP (P < 0.05).
Expression of miR-195 and Bcl-2 in NP cells
As demonstrated in Fig. 6, compared with the blank group, TNF-α group and TNF-α + miR-NC group had the increased expression of miR-195 and Bax and cleaved caspase 3 proteins, but declined Bcl-2 protein expression (all P < 0.05). Compared with TNF-α group, TNF-α + miR-195 inhibitors group was significantly downregulated in miR-195, Bax, and cleaved caspase 3 proteins, with the upregulated Bcl-2 protein (all P < 0.05), while TNF-α + siBcl-2 group showed no significant difference regarding miR-195 expression level (P > 0.05), but decreased in Bcl-2 protein and increased remarkably in Bax and cleaved caspase 3 proteins (all P < 0.05). With TNF-α + miR-195 inhibitors as baseline for comparison, TNF-α + miR-195 inhibitors + siBcl-2 group presented no observable difference in miR-195 expression in cells (P > 0.05), but showed a significant reduction in Bcl-2 protein and apparent enhancements in Bax and cleaved caspase 3 proteins (both P < 0.05).
MiR-195 inhibition alleviated IVDD in a rat model
A puncture-induced IVDD model was established in rats to evaluate the therapeutic effects of miR-195 inhibition on IVDD in vivo. X-ray images were taken and the results shown that DHI of punctured discs in punctured group was significantly decreased comparing to sham group, while DHI in punctured + antagomir-195 group was higher than that in the punctured group (all P < 0.05, Fig. 7A, B). Based on HE and TUNEL staining (Fig. 7C–E), it was observed that the histology score and NP cell apoptosis rates were remarkably increased in the punctured group compared to the sham group (all P < 0.05). However, the punctured + antagomir-195 group showed lower histology score and NP cell apoptosis rates compared with the punctured group (all P < 0.05).
In the first place, we observed significant miR-195 upregulation and Bcl-2 downregulation in NP tissues of IVDD patients. The elevated miR-195-5p was also observed in age-related macular degeneration (AMD) by using miRNA microarray chip detection, which was regarded as a potential biomarker for AMD diagnosis, as indicated by Chengda Ren et al. . On the other aspect, Bcl-2 expression was found to be dramatically downregulated, whereas Bax expression was remarkably upregulated in the rabbit IVDD model . Notably, Ping Cai et al. identified the increased expression of miR-15a, which belonged to the same family as miR-195, in NP tissues of IVDD, and in particular, over-expressed miR-15a can inhibit the Bcl-2 expression to promote the apoptosis of NP cells . Although miR-195 demonstrated different targets and functioned in different tissues or diseases, many studies pointed out a pathogenic role of miR-195 in inhibiting cell proliferation and promoting cell apoptosis [23,24,25]. More importantly, miR-195 expression was found negatively correlated with the Bcl-2 expression in our research, and the dual-luciferase reporter gene assay confirmed Bcl-2 to be a target gene of miR-195. At the same time, downregulation of miR-195 can inhibit ischemic cardiac apoptosis by targeting Bcl-2 . All these findings suggested that miR-195 can regulate the expression of its target gene Bcl-2 to promote the progression of IVDD.
The presence of a significant number of senescent cells were shown in degenerative nucleus pulposus, which can induce the expression of multiple inflammatory cytokines and matrix degrading enzymes to aggravate the living environment of NP cells, thereby affecting the growth and function of NP cells and further triggering the apoptosis of more cells . In fact, TNF-α is a multifunctional pro-inflammatory cytokine and considered to be a key factor in IVDD . As such, we constructed TNF-α-induced NP cell apoptosis model by referring to a previous study , aiming to observe the mechanism of miR-195 in inducing NP cell apoptosis in vitro. Firstly, we found that the proliferation of TNF-α-induced NP cells was dramatically decreased, while the cell apoptosis was apparently increased, which was in consistency with the previous findings [30, 31]. Besides, inhibiting miR-195 effectively enhanced the proliferation and limited the apoptosis of TNF-α-induced NP cells, whereas inhibiting Bcl-2 promoted NP cell apoptosis. Similarly, miR-199 was exhibited by Wei Wang et al. to mitigate TNF-α-induced NP cell apoptosis by targeted downregulation of MAP3K5, and thereby playing its protective role for NP cells . Also, HOTAIR can inhibit miR-34a expression to up-regulate the expression of its target gene Bcl-2 to further attenuate TNF-α-induced NP cell apoptosis . Here in this study, Bcl-2 siRNA can reverse the protective effect of miR-195 inhibitor on NP cells. Not surprisingly, Huaqing Zhu et al. noted that miR-195 may reduce Sirt1 and Bcl-2 expression to enhance the reactive oxygen species production and promote the apoptosis of palmitate-induced cardiomyocytes . Taken together, inhibiting miR-195 can inhibit TNF-α-induced NP cell apoptosis by targeted regulation of its target gene Bcl-2.
As for cell apoptosis in IVDD, it can occur through death receptor pathway, mitochondrial pathway and endoplasmic reticulum signaling pathway , while its apoptosis induced by endogenous pathway was initially found in mitochondria, namely mitochondrial pathway, which mainly exerts functions via Bcl-2 protein family . As a major anti-apoptotic member, Bcl-2 can maintain the outer mitochondrial membrane integrity . On the contrary, Bax, a pro-apoptotic member of the Bcl-2 family of proteins, mainly plays its regulatory role by destroying the integrity of mitochondrial membrane . Bcl-2 protein family can change the permeability of mitochondrial membrane and induce the opening of mitochondrial pore, thus allowing the apoptosis-inducing factor, cytochrome C, and pro-apoptotic protein into the cytoplasm, and finally inducing cell apoptosis by activating caspase [39, 40]. In agreement, we also found downregulated miR-195 can improve MMP of TNF-α-induced NP cells, elevate Bcl-2 protein, and reduce Bax and cleaved caspase 3 proteins, which however can be reversed by silencing Bcl-2. Besides, inhibition of miR-494 can effectively reduce Caspase-3 and Bax, and elevate Bcl-2, thus promoting the proliferation and hindering the apoptosis of NP cells . As reported by Ping Liu et al., miRNA-125a can upregulate anti-apoptotic protein Bcl-2 and inhibit Caspase-3 and Bax proteins by downregulating BAK1, thus inhibiting the apoptosis of NP cells . Moreover, Chang-Kui Gao et al. demonstrated that down-expressed miR-195 can elevate Bcl-2 but reduce Bax, Cyt-c, and caspase-3 to increase the MMP of cardiomyocytes and mitigate hypoxia re-oxygenation-induced cardiomyocyte apoptosis . Given the above, inhibiting miR-195 can specifically upregulate Bcl-2 to mediate mitochondrial apoptosis pathway, thus playing a protective role to reduce TNF-α-induced NP cell apoptosis. However, there was a limitation in this study. Due to resource limitations, the sample size of patients in the study is small. Thus, investigation with more study patients should be performed to clearly determine the relationships between miR-195 and prognosis of IVDD patients.
To sum up, we observed the increased miR-195 expression in NP tissues of IVDD patients, and inhibition of miR-195 could attenuate TNF-α-induced NP cells apoptosis by upregulating Bcl-2 expression. This study provides a new pathway and scientific basis for the clinical gene-based diagnosis, prevention, and treatment of IVDD.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Intervertebral disc degeneration
Mitochondrial membrane potential
Fetal bovine serum
Shen J, Fang J, Hao J, Zhong X, Wang D, Ren H, et al. SIRT1 Inhibits the catabolic effect of IL-1beta through TLR2/SIRT1/NF-kappaB pathway in human degenerative nucleus pulposus cells. Pain Physician. 2016;19(1):E215–26.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. https://doi.org/10.1016/S0140-6736(12)61728-0.
Wu X, Liu Y, Guo X, Zhou W, Wang L, Shi J, et al. Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-kappaB pathway in rats. Cell Death Dis. 2018;9(2):98. https://doi.org/10.1038/s41419-017-0151-z.
Xie L, Huang W, Fang Z, Ding F, Zou F, Ma X, et al. CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis. Cell Death Dis. 2019;10(10):751. https://doi.org/10.1038/s41419-019-1978-2.
Hanaei S, Abdollahzade S, Sadr M, Mirbolouk MH, Khoshnevisan A, Rezaei N. Association of IL10 and TGFB single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population: a case control study. BMC Med Genet. 2018;19(1):59. https://doi.org/10.1186/s12881-018-0572-2.
Urrutia J, Besa P, Lobos D, Campos M, Arrieta C, Andia M, et al. Lumbar paraspinal muscle fat infiltration is independently associated with sex, age, and inter-vertebral disc degeneration in symptomatic patients. Skeletal Radiol. 2018;47(7):955–61. https://doi.org/10.1007/s00256-018-2880-1.
Lin Y, Jiao Y, Yuan Y, et al. Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell apoptosis via the TLR2/JNK/mitochondrial-mediated pathway. Emerg Microbes Infect. 2018;7:1.
Zhao K, Zhang Y, Kang L, Song Y, Wang K, Li S, et al. Epigenetic silencing of miRNA-143 regulates apoptosis by targeting BCL2 in human intervertebral disc degeneration. Gene. 2017;628:259–66. https://doi.org/10.1016/j.gene.2017.07.043.
Singh R, Saini N. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis--a combined computational and experimental approach. J Cell Sci. 2012;125(Pt 6):1568–78. https://doi.org/10.1242/jcs.095976.
Li Z, Yu X, Shen J, Chan MTV, Wu WKK. MicroRNA in intervertebral disc degeneration. Cell Prolif. 2015;48(3):278–83. https://doi.org/10.1111/cpr.12180.
Liu W, Xia P, Feng J, Kang L, Huang M, Wang K, et al. MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration. Experimental cell research. 2017;359(1):39–49. https://doi.org/10.1016/j.yexcr.2017.08.011.
He JF, Luo YM, Wan XH, Jiang D. Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol. 2011;25(6):404–8. https://doi.org/10.1002/jbt.20396.
Cao X, Duan Z, Yan Z, Li Y, Li L, Sun J, et al. miR-195 contributes to human osteoarthritis via targeting PTHrP. J Bone Miner Metab. 2019;37(4):711–21. https://doi.org/10.1007/s00774-018-0973-5.
Yang XL, Cao CZ, Zhang QX. 2020. MiR-195 alleviates oxygen-glucose deprivation/reperfusion-induced cell apoptosis via inhibition of IKKalpha-mediated NF-kappaB pathway. Int J Neurosci:1-10.
Sudo H, Minami A. Regulation of apoptosis in nucleus pulposus cells by optimized exogenous Bcl-2 overexpression. J Orthop Res. 2010;28(12):1608–13. https://doi.org/10.1002/jor.21185.
Sun JC, Zheng B, Sun RX, Meng YK, Wang SM, Yang HS, et al. MiR-499a-5p suppresses apoptosis of human nucleus pulposus cells and degradation of their extracellular matrix by targeting SOX4. Biomed Pharmacother. 2019;113:108652. https://doi.org/10.1016/j.biopha.2019.108652.
Wang SS, Zhang W, Zhang YQ, Zhao Y, Liu Y, Li JK, et al. IL-17A enhances ADAMTS-7 expression through regulation of TNF-alpha in human nucleus pulposus cells. Journal of molecular histology. 2015;46(6):475–83. https://doi.org/10.1007/s10735-015-9640-5.
Issy AC, Castania V, Castania M, et al. 2013. Experimental model of intervertebral disc degeneration by needle puncture in Wistar rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 46:235-244.
Zhang Z, Xu T, Chen J, Shao Z, Wang K, Yan Y, et al. Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration. Cell death & disease. 2018;9(10):980. https://doi.org/10.1038/s41419-018-1024-9.
Ren C, Liu Q, Wei Q, Cai W, He M, du Y, et al. Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration. Cell Physiol Biochem. 2017;41(4):1413–23. https://doi.org/10.1159/000467941.
Shi L, Teng H, Zhu M, et al. Paeoniflorin inhibits nucleus pulposus cell apoptosis by regulating the expression of Bcl-2 family proteins and caspase-9 in a rabbit model of intervertebral disc degeneration. Exp Ther Med. 2015;10(1):257–62. https://doi.org/10.3892/etm.2015.2501.
Cai P, Yang T, Jiang X, Zheng M, Xu G, Xia J. Role of miR-15a in intervertebral disc degeneration through targeting MAP3K9. Biomed Pharmacother. 2017;87:568–74. https://doi.org/10.1016/j.biopha.2016.12.128.
Zhuang R, Rao JN, Zou T, Liu L, Xiao L, Cao S, et al. miR-195 competes with HuR to modulate stim1 mRNA stability and regulate cell migration. Nucleic Acids Res. 2013;41(16):7905–19. https://doi.org/10.1093/nar/gkt565.
Wang Y, Chen H, Fu Y, Ai A, Xue S, Lyu Q, et al. MiR-195 inhibits proliferation and growth and induces apoptosis of endometrial stromal cells by targeting FKN. Int J Clin Exp Pathol. 2013;6(12):2824–34.
Yang X, Yu J, Yin J, Xiang Q, Tang H, Lei X. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. Pharmazie. 2012;67(7):645–51.
Hang P, Sun C, Guo J, Zhao J, du Z. BDNF-mediates down-regulation of microRNA-195 inhibits ischemic cardiac apoptosis in rats. Int J Biol Sci. 2016;12(8):979–89. https://doi.org/10.7150/ijbs.15071.
Gruber HE, Ingram JA, Norton HJ, Hanley EN Jr. Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine (Phila Pa 1976). 2007;32(3):321–7. https://doi.org/10.1097/01.brs.0000253960.57051.de.
Holm S, Mackiewicz Z, Holm AK, Konttinen YT, Kouri VP, Indahl A, et al. Pro-inflammatory, pleiotropic, and anti-inflammatory TNF-alpha, IL-6, and IL-10 in experimental porcine intervertebral disk degeneration. Vet Pathol. 2009;46(6):1292–300. https://doi.org/10.1354/vp.07-VP-0179-K-FL.
Lin X, Lin Q. MiRNA-495-3p Attenuates TNF-alpha Induced Apoptosis and Inflammation in Human Nucleus Pulposus Cells by Targeting IL5RA. Inflammation. 2020;43(5):1797–805. https://doi.org/10.1007/s10753-020-01254-5.
Liu H, Pan H, Yang H, Wang J, Zhang K, Li X, et al. LIM mineralization protein-1 suppresses TNF-alpha induced intervertebral disc degeneration by maintaining nucleus pulposus extracellular matrix production and inhibiting matrix metalloproteinases expression. J Orthop Res. 2015;33(3):294–303. https://doi.org/10.1002/jor.22732.
Yu W, Fu J, Liu Y, Wu Y, Jiang D. Osteogenic protein-1 inhibits nucleus pulposus cell apoptosis through regulating the NF-kappaB/ROS pathway in an inflammation environment. Biosci Rep. 2018;38(6). https://doi.org/10.1042/BSR20181530.
Wang W, Guo Z, Yang S, Wang H, Ding W. Upregulation of miR-199 attenuates TNF-alpha-induced Human nucleus pulposus cell apoptosis by downregulating MAP3K5. Biochem Biophys Res Commun. 2018;505(3):917–24. https://doi.org/10.1016/j.bbrc.2018.09.194.
Yu Y, Zhang X, Li Z, Kong L, Huang Y. LncRNA HOTAIR suppresses TNF-alpha induced apoptosis of nucleus pulposus cells by regulating miR-34a/Bcl-2 axis. Biomed Pharmacother. 2018;107:729–37. https://doi.org/10.1016/j.biopha.2018.08.033.
Zhu H, Yang Y, Wang Y, Li J, Schiller PW, Peng T. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 2011;92(1):75–84. https://doi.org/10.1093/cvr/cvr145.
Wang H, Liu H, Zheng ZM, Zhang KB, Wang TP, Sribastav SS, et al. Role of death receptor, mitochondrial and endoplasmic reticulum pathways in different stages of degenerative human lumbar disc. Apoptosis. 2011;16(10):990–1003. https://doi.org/10.1007/s10495-011-0644-7.
Russo A, Cardile V, Graziano ACE, Avola R, Bruno M, Rigano D. Involvement of Bax and Bcl-2 in Induction of Apoptosis by Essential Oils of Three Lebanese Salvia Species in Human Prostate Cancer Cells. Int J Mol Sci. 2018;19(1). https://doi.org/10.3390/ijms19010292.
Opferman JT, Kothari A. Anti-apoptotic BCL-2 family members in development. Cell Death Differ. 2018;25(1):37–45. https://doi.org/10.1038/cdd.2017.170.
Liu XF, Jiang H, Zhang CS, Yu SP, Wang ZQ, Su HL. Targeted drug regulation on methylation of p53-BAX mitochondrial apoptosis pathway affects the growth of cholangiocarcinoma cells. J Int Med Res. 2012;40(1):67–75. https://doi.org/10.1177/147323001204000107.
Yue B, Lin Y, Ma X, Zhang G, Chen B. Effect of Survivin gene therapy via lentivirus vector on the course of intervertebral disc degeneration in an in vivo rabbit model. Mol Med Rep. 2016;14(5):4593–8. https://doi.org/10.3892/mmr.2016.5830.
Wang Q, Zhang L, Yuan X, Ou Y, Zhu X, Cheng Z, et al. The relationship between the Bcl-2/Bax proteins and the mitochondria-mediated apoptosis pathway in the differentiation of adipose-derived stromal cells into neurons. PLoS One. 2016;11(10):e0163327. https://doi.org/10.1371/journal.pone.0163327.
Li L, Zhang L, Zhang Y. 2018. Roles of miR-494 in Intervertebral Disk Degeneration and the Related Mechanism. World Neurosurg.
Liu P, Chang F, Zhang T, Gao G, Yu C, Ding SQ, et al. Downregulation of microRNA-125a is involved in intervertebral disc degeneration by targeting pro-apoptotic Bcl-2 antagonist killer 1. Iran J Basic Med Sci. 2017;20(11):1260–7. https://doi.org/10.22038/IJBMS.2017.9542.
Gao CK, Liu H, Cui CJ, et al. Roles of microRNA-195 in cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion injury. J Genet. 2016;95(1):99–108. https://doi.org/10.1007/s12041-016-0616-3.
The authors appreciate the reviewers for their useful comments in this paper.
There was no funding in this study.
Ethics approval and consent to participate
The experimental protocol in this study was approved by Ethics Committee of The Second Hospital of Liaocheng Affiliated to Shandong First Medical University. All participants and their guardians were well-informed and signed the informed consent form prior to the study. All animal studies were approved by the Institutional Animal Research Committee of The Second Hospital of Liaocheng Affiliated to Shandong First Medical University.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lin, XL., Zheng, ZY., Zhang, QS. et al. Expression of miR-195 and its target gene Bcl-2 in human intervertebral disc degeneration and their effects on nucleus pulposus cell apoptosis. J Orthop Surg Res 16, 412 (2021). https://doi.org/10.1186/s13018-021-02538-8
- Intervertebral disc degeneration
- Nucleus pulposus cells